IRMD
IRadimed Powers Ahead with Record Q2 Revenues, Eyes $100 Million Run Rate
IRadimed Corporation has announced a stellar performance in its second quarter of 2025, with revenues reaching $20.4 million - a 14% increase over the same period last year. This marks the company's 16th consecutive quarter of record revenues. CEO Roger Susi attributed the success to strong demand